Cargando…

A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults

BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou Serhal, R., Salameh, P., Wakim, N., Issa, C., Kassem, B., Abou Jaoude, L., Saleh, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985068/
https://www.ncbi.nlm.nih.gov/pubmed/29887993
http://dx.doi.org/10.1155/2018/3934296
_version_ 1783328697820905472
author Bou Serhal, R.
Salameh, P.
Wakim, N.
Issa, C.
Kassem, B.
Abou Jaoude, L.
Saleh, N.
author_facet Bou Serhal, R.
Salameh, P.
Wakim, N.
Issa, C.
Kassem, B.
Abou Jaoude, L.
Saleh, N.
author_sort Bou Serhal, R.
collection PubMed
description BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. METHODOLOGY: A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. RESULTS: 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. CONCLUSION: This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients.
format Online
Article
Text
id pubmed-5985068
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59850682018-06-10 A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults Bou Serhal, R. Salameh, P. Wakim, N. Issa, C. Kassem, B. Abou Jaoude, L. Saleh, N. Int J Hypertens Research Article BACKGROUND: A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. METHODOLOGY: A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. RESULTS: 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. CONCLUSION: This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients. Hindawi 2018-05-20 /pmc/articles/PMC5985068/ /pubmed/29887993 http://dx.doi.org/10.1155/2018/3934296 Text en Copyright © 2018 R. Bou Serhal et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bou Serhal, R.
Salameh, P.
Wakim, N.
Issa, C.
Kassem, B.
Abou Jaoude, L.
Saleh, N.
A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title_full A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title_fullStr A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title_full_unstemmed A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title_short A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults
title_sort new lebanese medication adherence scale: validation in lebanese hypertensive adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985068/
https://www.ncbi.nlm.nih.gov/pubmed/29887993
http://dx.doi.org/10.1155/2018/3934296
work_keys_str_mv AT bouserhalr anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT salamehp anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT wakimn anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT issac anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT kassemb anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT aboujaoudel anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT salehn anewlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT bouserhalr newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT salamehp newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT wakimn newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT issac newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT kassemb newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT aboujaoudel newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults
AT salehn newlebanesemedicationadherencescalevalidationinlebanesehypertensiveadults